Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126614921 | 12661492 | 1 | I | 201607 | 20160726 | 20160817 | 20160817 | PER | US-PFIZER INC-2016364431 | PFIZER | 70.00 | YR | F | Y | 97.51000 | KG | 20160817 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126614921 | 12661492 | 1 | PS | REVATIO | SILDENAFIL CITRATE | 1 | UNK | 21845 | FILM-COATED TABLET | ||||||||||
| 126614921 | 12661492 | 2 | SS | TYVASO | TREPROSTINIL | 1 | UNK, 4X/DAY (54-72 MICROGRAMS) | 2100813 | 0 | QID | |||||||||
| 126614921 | 12661492 | 3 | SS | TYVASO | TREPROSTINIL | 1 | UNK (DOSE DUE TO THE EVENT 9-12 BREATHS ) | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126614921 | 12661492 | 2 | Pulmonary arterial hypertension |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126614921 | 12661492 | Cough | |
| 126614921 | 12661492 | Drug ineffective | |
| 126614921 | 12661492 | Dyspnoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126614921 | 12661492 | 2 | 20110404 | 0 |